MO

Makoto Ohori

Partner | Chief Investment Officer, Life Science at UTokyo Innovation Platform

Tokyo, Japan

About

Makoto Ohori is a Partner and Chief Investment Officer at UTokyo Innovation Platform. Dr. Ohori received his Ph.D. in Pharmaceutical Sciences from the University of Tokyo, where his doctoral research focused on drug discovery and pharmacological evaluation of novel kinase inhibitors for autoimmune diseases. Dr. Ohori has collaborated with various institutions, such as Grenoble University Hospital, Kyoto University Hospital, Dokkyo University School of Medicine, Trevigen, Inc etc. He authored more than fifteen peer reviewed articles and invited reviews.

Position in the VCSift Database

  • 5 investors at UTokyo Innovation Platform are tracked.
  • 1 investors hold the Partner | Chief Investment Officer, Life Science role in VCSift. Makoto Ohori is one of them.
  • 2,068 investors are based in Tokyo, Tokyo, Japan.

Data sourced from 410,343 investor profiles. Updated July 2026.

Investment Focus

Contact Information

em••••@example.com
linkedin.com/in/••••••••

Unlock contact details with a VCSift subscription

Unlock Contact

Already subscribed? Log in

Find more investors like Makoto

Search Investors